Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;9(4):797-807.
doi: 10.1007/s40123-020-00304-3. Epub 2020 Sep 24.

Therapeutic Instruments Targeting Meibomian Gland Dysfunction

Affiliations
Review

Therapeutic Instruments Targeting Meibomian Gland Dysfunction

Laura Valencia-Nieto et al. Ophthalmol Ther. 2020 Dec.

Abstract

The most prevalent type of meibomian gland dysfunction (MGD), which is obstructive, is the main cause of evaporative dry eye and is characterized by changes in the meibum composition and duct obstruction. Eyelid hygiene has usually been the most common clinical approach. However, alternative therapies for MGD are emerging on the market. Some warming and humidity devices have led to an improvement in the signs and symptoms in MGD patients. Likewise, eyelid massaging and cleaning devices are also beneficial for ocular signs and symptoms; however, patients usually need more than one session to maintain the therapeutic effect. Thermal pulsation has been reported to be more efficient than other strategies, and the effects can last up to 12 months. Moreover, intense pulsed light therapy has been demonstrated to improve ocular signs and symptoms alone and in combination with other therapies. Proper counseling of clinicians considering MGD status and patient compliance will help patients to undergo the adequate technique that best suits their condition.

Keywords: Eyelid hygiene; Intense pulsed light; Meibomian gland dysfunction; Thermal pulsation.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Nelson JD, Shimazaki J, Benitez-del-Castillo JM, et al. The International Workshop on Meibomian Gland Dysfunction: report of the definition and classification subcommittee. Investig Ophthalmol Vis Sci. 2011;52(4):1930–1937. - PMC - PubMed
    1. Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The International Workshop on Meibomian Gland Dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for. MGD Investig Ophthalmol Vis Sci. 2011;52(4):1994–2005. - PMC - PubMed
    1. Knop E, Knop N, Millar T, Obata H, Sullivan DA. The International Workshop on Meibomian Gland Dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Investig Opthalmol Vis Sci. 2011;52(4):1938. - PMC - PubMed
    1. Green-Church KB, Butovich I, Willcox M, et al. The International Workshop on Meibomian Gland Dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease. Investig Opthalmol Vis Sci. 2011;52(4):1979. - PMC - PubMed
    1. Butovich IA, Millar TJ, Ham BM. Understanding and analyzing meibomian lipids—a review. Curr Eye Res. 2008;33(5–6):405–420. - PMC - PubMed

LinkOut - more resources